Phibro Animal Health Corp. (PAHC): Price and Financial Metrics

PAHC POWR Grades

• PAHC scores best on the Value dimension, with a Value rank ahead of 92.38% of US stocks.
• The strongest trend for PAHC is in Growth, which has been heading down over the past 178 days.
• PAHC ranks lowest in Momentum; there it ranks in the 13th percentile.

PAHC Stock Summary

• PHIBRO ANIMAL HEALTH CORP's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 86.17% of US listed stocks.
• Of note is the ratio of PHIBRO ANIMAL HEALTH CORP's sales and general administrative expense to its total operating expenses; 87.09% of US stocks have a lower such ratio.
• With a price/sales ratio of 0.61, PHIBRO ANIMAL HEALTH CORP has a higher such ratio than merely 21.3% of stocks in our set.
• Stocks that are quantitatively similar to PAHC, based on their financial statements, market capitalization, and price volatility, are HFFG, BDL, APWC, RCKY, and DLTH.
• Visit PAHC's SEC page to see the company's official filings. To visit the company's web site, go to www.pahc.com.

PAHC Valuation Summary

• In comparison to the median Healthcare stock, PAHC's price/earnings ratio is 28.32% lower, now standing at 16.2.
• PAHC's EV/EBIT ratio has moved down 3.7 over the prior 109 months.

Below are key valuation metrics over time for PAHC.

PAHC Growth Metrics

Its 5 year net income to common stockholders growth rate is now at -43.04%.
• Its 5 year revenue growth rate is now at 7.87%.
• Its year over year net cashflow from operations growth rate is now at -32.51%.

PAHC's revenue has moved up $145,328,000 over the prior 52 months.

The table below shows PAHC's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	972.051	-5.481	36.242
2022-09-30	960.117	17.13	46.497
2022-06-30	942.261	31.649	49.175
2022-03-31	907.274	33.145	58.809
2021-12-31	879.384	43.638	53.281
2021-09-30	852.821	50.429	48.617

PAHC's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• PAHC has a Quality Grade of C, ranking ahead of 53.34% of graded US stocks.
• PAHC's asset turnover comes in at 1.029 -- ranking 22nd of 681 Pharmaceutical Products stocks.
• CLVS, ELTP, and AZN are the stocks whose asset turnover ratios are most correlated with PAHC.

The table below shows PAHC's key quality metrics over time.